lorazepam has been researched along with haloperidol in 172 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (11.63) | 18.7374 |
| 1990's | 32 (18.60) | 18.2507 |
| 2000's | 58 (33.72) | 29.6817 |
| 2010's | 46 (26.74) | 24.3611 |
| 2020's | 16 (9.30) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, PR; Craik, DJ; Martin, JL | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
| Abraham, MH; Acree, WE; Ibrahim, A | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Fine, F; Walker, DJ | 1 |
| Woodbury, MA; Woodbury, MM | 1 |
| Gaertner, HJ; Mahal, A; Stevens, A; Stevens, I | 1 |
| Creelman, WL; Lenox, RH; Newhouse, PA; Whitaker, TM | 1 |
| Fink, M; Francis, A | 1 |
| Flowers, E; Glassman, R; Miyawaki, E; Rood, L; Salzman, C; Solomon, D; Thayer, S | 1 |
| Patkar, AA; Shah, LP | 1 |
| Holland, J; Stiefel, F | 1 |
| Chandler, JD | 1 |
| Francom, M | 1 |
| Hales, RE; Silver, JM; Yudofsky, SC | 1 |
| Adams, F | 1 |
| Merrell, AN; Ryken, TC | 1 |
| Fernandez, F; Levy, JK; Mansell, PW | 1 |
| Alexander, WF; Garza-Treviño, ES; Hollister, LE; Overall, JE | 1 |
| Backonja, M; Beinlich, B; Dulli, D; Schutta, HS | 1 |
| Chouinard, G | 1 |
| Rosenbloom, A | 1 |
| Salzman, C | 1 |
| Calvert, JE; Gelbtuch, MH; Harris, JP; Phillipson, OT | 1 |
| Green, AI; Jaskiw, GI; Rodriguez-Villa, F; Salzman, C | 1 |
| Campbell, R; Simpson, GM | 1 |
| Adams, F; Andersson, BS; Fernandez, F | 1 |
| Ellison, JM | 1 |
| Coates, A; Fox, RM; Friedlander, ML; Hedley, D; Kearsley, JH; Raghavan, D; Sims, K; Tattersall, MH | 1 |
| Friedlander, ML; Kearsley, JH; Sims, K | 1 |
| Cassem, NH; Fricchione, GL; Hobson, D; Hooberman, D | 1 |
| Ladee, GA; Moleman, P; Schmitz, PJ | 1 |
| Brown, ES; Lambert, MT | 1 |
| Fowler, SB; Hertzog, J; Wagner, BK | 1 |
| Silva, RG; Tolstunov, L | 1 |
| Shenoy, RS | 1 |
| Jäger, A; Marneros, A | 1 |
| Tesar, GE | 1 |
| Breitbart, W; Corbera, K; Derevenco, M; Grau, C; Jacobson, P; Lund, S; Marotta, R; Platt, MM; Raymond, S; Weisman, H | 1 |
| Finnerty, M; Levin, Z; Miller, LJ | 1 |
| Northoff, G; Pflug, B; Wenke, J | 1 |
| Grande Rodríguez, S; Real Rodríguez, B; Ruibal, JL; Sueiro Pita, B | 1 |
| Green, JF; King, DJ; Lynch, G | 1 |
| Fuh, JL; Liu, CY; Liu, HC; Wang, SJ; Yang, YY | 1 |
| Kline, JA; Medlin, RP; Ransom, MM; Watts, JA | 1 |
| Beck, M; Buchbinder, D; Galen, DM | 1 |
| Battaglia, J; Dubin, W; Goodman, L; Kang, J; Leedom, L; McGlynn, C; Mendoza, R; Moss, S; Rush, J | 1 |
| Berman, ME; Foster, S; Kessel, J; Simpson, GM | 1 |
| Byth, W; Green, JF; King, DJ; Lynch, G; Wilson-Davis, K | 1 |
| Hillard, JR | 1 |
| Bouman, NH; Dhossche, DM | 1 |
| Aznar, E; Climent, MA; Guillem, V; Olmos, T; Palau, J; Ruiz, A; Soriano, V | 1 |
| Hughes, DH | 1 |
| Allen, MH; Charles, O; Chou, JC; Czobor, P; Trujillo, M; Tuma, I; Volavka, J; Winsberg, B | 1 |
| Berthiaume, D; Fraser, GL; Prato, BS; Riker, RR; Wilkins, ML | 1 |
| Childs, A; Stanislav, SW | 1 |
| Billig, N; Cohen-Mansfield, J; Lipson, S; Taylor, L; Werner, P; Woosley, R | 1 |
| Currier, GW; Simpson, GM | 1 |
| Fitzmaurice, SC; Mullins, ME | 1 |
| Bell, R; Campbell, C; Green, JF; King, DJ; McCartan, D; Pickering, A; Trimble, K | 1 |
| Hatch, CD; Lund, BC; Perry, PJ | 1 |
| Cherkerzian, S; Cohen, BM; Lange, N; Ma, J; Wager, C; Ye, N | 1 |
| Alaka, K; Battaglia, J; Lindborg, SR; Meehan, K; Wright, P | 1 |
| Amabile, CM; Couillard, D; Norcross, ED; Simpson, KN; Stanley, KM; Worrall, CL | 1 |
| Sielk, M | 1 |
| Coffey, B | 1 |
| Bossie, CA; Chou, JC; Currier, GW; Feifel, D; Gharabawi, GM; Mahmoud, RA; Turkoz, I | 1 |
| Jackson, KC; Lipman, AG | 1 |
| Ahl, J; Kinon, BJ; McMullen, E; Rotelli, MD | 1 |
| Dresden, GM; Levitt, MA; Nobay, F; Simon, BC | 1 |
| Adams, C; Alexander, J; John, T; Mol, C; Philip, J; Tharyan, P | 1 |
| Arnold, RM; Buss, MK | 1 |
| Burke, M; Flockhart, D; Gorski, JC; Greenblatt, DJ; Harvey, AT; Preskorn, SH; Werder, S | 1 |
| Eerdekens, M; Grossman, F; Karcher, K; Khanna, S; Kramer, M; Smulevich, AB | 1 |
| Cho, BH; Jung, IK; Lee, HJ | 1 |
| Alexander, J; Allen, MH; Huf, G | 1 |
| Amador, F; Nakasato, Y; Servat, J; Teasdale, TA | 1 |
| Belgamwar, RB; Fenton, M | 1 |
| Basu, D; Jhirwal, OP; Kulhara, P | 1 |
| Chandra, PS; Ranjan, S | 1 |
| Jiloha, RC; Mendhekar, DN | 1 |
| Lunsford, SL; Miller, JG; Simpson, KN; Spencer, AP; Stanley, KM; Worrall, CL | 1 |
| Weschules, DJ | 1 |
| Lewin, MR; Montauk, L; Nobay, F; Shalit, M | 1 |
| Francis, A; Kohen, I; Preval, H; Southard, R | 1 |
| Barnes, BJ; Lunsford, SL; Miller, JG; Moeller, KE; Simpson, KN; Spencer, AP; Stanley, KM; Worrall, CL | 1 |
| Gill, SS; Seitz, D | 1 |
| Currier, GW; McMullan, JT; Veser, BD; Veser, FH; Zealberg, J | 1 |
| Hulstijn, W; Ruigt, GS; Sabbe, BG; Verkes, RJ; Wezenberg, E | 1 |
| Ebner, F; Enzinger, C; Simbrunner, J; Wehrschuetz, M | 1 |
| Cotroneo, A; De Fazio, P; De Fazio, S; De Sarro, G; Gallelli, L; Gareri, P; Lacava, R | 1 |
| Citrome, LL; Crandall, DT; Currier, GW; Manos, G; McQuade, R; Oren, D; Pikalov, AA; Zimbroff, DL | 1 |
| Spina, SP; Taddei, A | 1 |
| Arai, H; Hatta, K; Miyakawa, K; Nakamura, H; Ota, T; Usui, C | 1 |
| Preskorn, SH | 1 |
| Bardia, A; Bhaskara, A; Bleicher, J; Constantino, S; Huyck, T; Loprinzi, CL; Silberstein, PT | 1 |
| Cantrell, FL; Vohra, R; Williams, SR | 1 |
| Birkenhager, TK; Bruijn, JA; Moleman, P; Mulder, PG; van den Broek, WW | 1 |
| Caballero, J; Gonzalez-Blanco, M | 1 |
| Kutscher, E; Peterson, E; Stoebner, A; Weatherill, J | 1 |
| Amabile, GA; Giacomini, P; Marchione, P; Marianetti, M; Romeo, T; Vento, C | 1 |
| Alexander, J; Allen, MH; Huf, G; Raveendran, NS | 1 |
| Hewer, W; Kauder, E; Vierling, P | 1 |
| Adams, CE; Coutinho, ES; Huf, G | 1 |
| Kalra, B; Mendhekar, DN; Sekhar, S; Tekur, U | 1 |
| Dyer, C | 1 |
| Ban, K; Birmingham, C; Bramwell, K; Davis, D; Rosen, P; Sakles, J; Sanchez, LD; Wolfe, R | 1 |
| Kashyap, GL; Patel, AG | 1 |
| Bak, M; Marcelis, M; van Os, J | 1 |
| Gugger, JJ; Saad, M; Smith, C | 1 |
| Coyne, PJ; Dodson, P; Fletcher, D; Parker, G; Poklis, JL; Ritter, JK; Smith, TJ | 1 |
| Girard, TD | 1 |
| Praharaj, SK; Selvaraj, AG | 1 |
| Candy, B; Jackson, KC; Jones, L; King, M; Leurent, B; Tookman, A | 1 |
| Adams, CE; Jones, H; Powney, MJ | 1 |
| Aldana-Bernier, L; Bhojani, S; Pawelzik, T; Sikder, M | 1 |
| Golla, H; Perrar, KM; Voltz, R | 1 |
| Beck, A; Gillies, D; Rathbone, J; Sampson, S | 1 |
| Dorokhine, I; Knapp, CM; Musuku, M; Patel, N; Zirker, W | 1 |
| Reti, IM; Wachtel, LE; Ying, H | 1 |
| Akgün, KM; Araujo, KL; Bramley, K; Murphy, TE; Pisani, MA; Vest, MT | 1 |
| Adams, BD; Hughes, DW; Lepori, L; Vanwert, E | 1 |
| Fischer, P; Scharfetter, J | 1 |
| Abdellaziz, J; Imen, B; Ines, F; Jawaher, M; Rim, S | 1 |
| Akhileswaran, R; Heng, CP; Hui, D; Tan, A; Yap, R | 1 |
| Coyne, PJ; Dodson, PW; Fletcher, DS; Parker, GG; Smith, TJ; Wan, W | 1 |
| Glezer, A; Yuan, N | 1 |
| Chen, HH; Chen, YH; Hsieh, MH; Huang, CL; Huang, GH; Hwang, TJ; Hwu, HG | 1 |
| Hayes, A; Russ, MJ | 1 |
| Burns, K; Burry, L; Cook, D; Devlin, JW; Dodek, P; Ferguson, N; Fergusson, D; Fowler, RA; Granton, J; Jacka, M; Keenan, S; Luk, E; Mallick, R; Mehta, S; Olafson, K; Reynolds, S; Rose, L; Skrobik, Y; Steinberg, M; Tanios, M | 1 |
| Dorman, S; Murray-Brown, F | 1 |
| Cameron, R | 1 |
| Alexander, J; Allen, MH; Gandhi, P; Huf, G | 1 |
| Benowitz, NL; Horng, H; Smollin, CG; Vo, KT | 1 |
| Bailey, AM; Baum, RA; Horn, K; Justice, SN; Lewis, T; Morizio, K; Schultz, A; Weant, K | 1 |
| Gowdappa, B; Ram, D; Raman, R | 1 |
| Amin, S; Breitbart, W; Bruera, E; De La Cruz, M; Delgado-Guay, M; Dibaj, SS; Epner, D; Frisbee-Hume, S; Hall, S; Hess, K; Hui, D; Liu, D; Nguyen, T; Reddy, A; Tanco, K; Vidal, M; Walker, P; Williams, J; Wilson, A; Zhukovsky, DS | 1 |
| Ghosh, AK; Kathirvel, N | 1 |
| Bondi, CO; Cheng, JP; Free, KE; Kline, AE; Leary, JB; Meyer, EA; O'Neil, DA | 1 |
| Arthur, J; Bruera, E; Dalal, S; Dev, R; Dibaj, SS; Hess, K; Hui, D; Reddy, S | 1 |
| Aggarwal, N; Kataria, D; Prakash, R; Prasad, S | 1 |
| Horng, H; Li, K; Lynch, K; Smollin, CG | 1 |
| Shrikant Kulkarni, N | 1 |
| Hardman, MI; Sprung, J; Weingarten, TN | 1 |
| Cole, JB; Driver, BE; Klein, LR; Mullinax, SZ; Nordstrom, KD; Wilson, MP | 1 |
| Bak, E; Bak, M; Bervoets, C; Bienkowski, P; De Fruyt, J; Dom, G; Drukker, M; Fiorillo, A; Frydecka, D; Misiak, B; Preuss, WU; Samochowiec, A; Samochowiec, J; Sampogna, G; Weltens, I | 1 |
| Carvalho, AF; Chen, TY; Chen, YW; Chu, CS; Hsu, CY; Liang, CS; Lin, PY; Matsuoka, YJ; Stubbs, B; Su, KP; Tseng, PT; Tu, YK; Wada, S; Wu, YC; Yeh, TC | 1 |
| Forest, CP; Smith, TN; Walsh, A | 1 |
| Candy, B; Finucane, AM; Jones, L; Leurent, B; Sampson, EL; Stone, P; Tookman, A | 1 |
| Chen, J; Jin, Y; Li, N; Li, Y; Ma, J; Mu, W; Shang, HC; Si, JH; Wang, J; Zheng, R | 1 |
| Hernández-Salas, LP; Herrera-Huerta, CA; Magallanes-Cano, EM | 1 |
| Calvo, R; Cannis, M; Figuerado, Y; Lee, J; Lin, J; Montgomery, A; Norton, VC; Sikand, H | 1 |
| Barbe, N; Coffey, BJ; Miller, M; Poulsen, RJ | 1 |
| Gropp, C; Jaworowski, S; Malka, M; Weiser, M | 1 |
| Bailey, TA; Blaszczyk, AT; Tapia, S | 1 |
| Bruera, E; Chen, M; Hui, D; Tang, M | 1 |
| Conrardy, MJ; Cruz, DS; Fant, AL; Kim, HS; Lank, PM; Malik, S; Tyler, DJ | 1 |
| Huecker, M; Javed, J; Roy, D; Senn, J; Shaw, I; Shreffler, J; Thiemann, P; Thomas, A | 1 |
| Darling, B; Edwards, C; Jeffers, T; Vadiei, N | 1 |
| Osser, DN; Stetson, SR | 1 |
| Dagenais-Beaulé, V; Djerroud, L; Leclair, G; Sullivan, T | 1 |
| Allen, PJ; Johanson, KE; Lock, AE; Neff, LA; Reveles, KR | 1 |
| Brown, JM; Dhana, L; Lonsdale, H; Wilsey, MJ | 1 |
| Al-Tabakha, MM; Babu, RJ; Boddu, SHS; Jacob, S; Neupane, R; Tiwari, AK | 1 |
34 review(s) available for lorazepam and haloperidol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Neuroleptic-induced catatonia as a stage in the progression toward neuroleptic malignant syndrome.
Topics: Adolescent; Catatonia; Drug Therapy, Combination; Haloperidol; Humans; Lorazepam; Male; Neuroleptic Malignant Syndrome; Neurologic Examination; Psychotic Disorders; Trifluoperazine | 1992 |
Delirium in cancer patients.
Topics: Aged; Delirium; Diagnosis, Differential; Haloperidol; Humans; Lorazepam; Neoplasms; Neuropsychological Tests | 1991 |
Pharmacologic management of aggression in the elderly.
Topics: Aged; Aggression; Antipsychotic Agents; Benzodiazepines; Buspirone; Dementia; Haloperidol; Humans; Lorazepam; Neurocognitive Disorders | 1990 |
Management of delirium in terminally ill AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Delirium; Haloperidol; Humans; Injections, Intravenous; Lorazepam; Prospective Studies; Psychiatric Status Rating Scales | 1989 |
Emerging treatment options in the alcohol withdrawal syndrome.
Topics: Adrenergic beta-Antagonists; Alcohol Withdrawal Delirium; Benzodiazepines; Drug Therapy, Combination; Ethanol; Haloperidol; Humans; Infusions, Intravenous; Lorazepam; Substance Withdrawal Syndrome | 1988 |
Use of benzodiazepines to control disruptive behavior in inpatients.
Topics: Aggression; Benzodiazepines; Haloperidol; Hospitalization; Humans; Injections, Intramuscular; Lorazepam; Psychomotor Agitation; Psychotic Disorders | 1988 |
Pharmacological interventions for agitation in head-injured patients in the acute care setting.
Topics: Adult; Brain Injuries; Critical Care; Dose-Response Relationship, Drug; Drug Administration Schedule; Haloperidol; Humans; Lorazepam; Male; Midazolam; Multiple Trauma; Neurologic Examination; Nursing Assessment; Propofol; Psychomotor Agitation | 1995 |
The agitated patient, Part II: Pharmacologic treatment.
Topics: Akathisia, Drug-Induced; Drug Therapy, Combination; Emergencies; Haloperidol; Humans; Lorazepam; Neurocognitive Disorders; Psychomotor Agitation; Substance-Related Disorders; Tranquilizing Agents | 1993 |
[The neuroleptic malignant syndrome in an adolescent. Its treatment with dantrolene, bromocryptin and diazepam].
Topics: Adolescent; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Antipsychotic Agents; Bromocriptine; Dantrolene; Diazepam; Drug Therapy, Combination; Haloperidol; Humans; Imipramine; Lorazepam; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Time Factors | 1996 |
Emergency treatment of acute psychosis.
Topics: Acute Disease; Antipsychotic Agents; Benzodiazepines; Clozapine; Decision Trees; Drug Administration Schedule; Emergency Services, Psychiatric; Emergency Treatment; Haloperidol; History, 20th Century; Humans; Lorazepam; Olanzapine; Pirenzepine; Psychotic Disorders; Risperidone | 1998 |
Acute psychopharmacological management of the aggressive psychotic patient.
Topics: Acute Disease; Aggression; Antipsychotic Agents; Dose-Response Relationship, Drug; Haloperidol; Humans; Lorazepam; Patient Compliance; Psychotic Disorders | 1999 |
[Problems with the treatment of schizophrenics in the doctor's office].
Topics: Acute Disease; Adult; Anti-Anxiety Agents; Antipsychotic Agents; Diazepam; Drug Therapy, Combination; Emergencies; Family Practice; Female; Haloperidol; Humans; Lorazepam; Male; Physician-Patient Relations; Schizophrenia; Time Factors | 2003 |
Drug therapy for delirium in terminally ill patients.
Topics: Antipsychotic Agents; Chlorpromazine; Delirium; Haloperidol; Humans; Lorazepam; Terminally Ill | 2004 |
Haloperidol plus promethazine for psychosis induced aggression.
Topics: Aggression; Drug Therapy, Combination; Haloperidol; Humans; Lorazepam; Midazolam; Promethazine; Psychomotor Agitation; Psychotic Disorders; Randomized Controlled Trials as Topic | 2005 |
Olanzapine IM or velotab for acutely disturbed/agitated people with suspected serious mental illnesses.
Topics: Aggression; Antipsychotic Agents; Benzodiazepines; Haloperidol; Humans; Injections, Intramuscular; Lorazepam; Olanzapine; Psychotic Disorders; Randomized Controlled Trials as Topic | 2005 |
Haloperidol plus promethazine for psychosis-induced aggression.
Topics: Aggression; Benzodiazepines; Drug Therapy, Combination; Haloperidol; Humans; Lorazepam; Midazolam; Olanzapine; Promethazine; Psychomotor Agitation; Psychotic Disorders; Randomized Controlled Trials as Topic | 2009 |
[Haloperidol plus promethazine for agitated patients--a systematic review].
Topics: Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Haloperidol; Humans; Lorazepam; Midazolam; Olanzapine; Promethazine; Psychomotor Agitation; Randomized Controlled Trials as Topic | 2009 |
[Rapid tranquillisation; review of the literature and recommendations].
Topics: Aggression; Benzodiazepines; Conscious Sedation; Drug Therapy, Combination; Haloperidol; Humans; Hypnotics and Sedatives; Lorazepam; Midazolam; Olanzapine; Practice Guidelines as Topic; Promethazine; Psychotic Disorders; Time Factors; Treatment Outcome | 2011 |
Brain dysfunction in patients with chronic critical illness.
Topics: Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Chronic Disease; Coma; Comorbidity; Critical Illness; Delirium; Haloperidol; Humans; Hypnotics and Sedatives; Lorazepam | 2012 |
Drug therapy for delirium in terminally ill adult patients.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Delirium; Haloperidol; Humans; Lorazepam; Randomized Controlled Trials as Topic; Terminally Ill | 2012 |
Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation).
Topics: Aggression; Antipsychotic Agents; Aripiprazole; Clopenthixol; Dystonia; Haloperidol; Humans; Lorazepam; Piperazines; Psychomotor Agitation; Psychotic Disorders; Quinolones; Randomized Controlled Trials as Topic; Sleep; Thiazoles | 2012 |
[Pharmacological treatment of delirium in palliative care patients. A systematic literature review].
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clinical Trials as Topic; Delirium; Evidence-Based Medicine; Haloperidol; Humans; Hypnotics and Sedatives; Lorazepam; Olanzapine; Palliative Care; Piperazines; Quinolones; Risk Factors | 2013 |
Benzodiazepines for psychosis-induced aggression or agitation.
Topics: Acute Disease; Aggression; Anti-Dyskinesia Agents; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Emergency Treatment; Haloperidol; Humans; Lorazepam; Olanzapine; Psychomotor Agitation; Psychotic Disorders; Randomized Controlled Trials as Topic | 2013 |
Haloperidol for the treatment of nausea and vomiting in palliative care patients.
Topics: Antiemetics; Diphenhydramine; Gels; Haloperidol; Humans; Lorazepam; Nausea; Palliative Care; Randomized Controlled Trials as Topic; Vomiting | 2015 |
Haloperidol plus promethazine for psychosis-induced aggression.
Topics: Aggression; Benzodiazepines; Drug Therapy, Combination; Haloperidol; Humans; Lorazepam; Midazolam; Promethazine; Psychomotor Agitation; Psychotic Disorders; Randomized Controlled Trials as Topic; Restraint, Physical | 2016 |
Review of Intranasally Administered Medications for Use in the Emergency Department.
Topics: Administration, Intranasal; Anesthetics, Dissociative; Anticonvulsants; Antidotes; Antipsychotic Agents; Dexmedetomidine; Emergency Service, Hospital; Fentanyl; Flumazenil; Haloperidol; Humans; Hydromorphone; Hypnotics and Sedatives; Ketamine; Lorazepam; Midazolam; Naloxone; Narcotic Antagonists; Narcotics | 2017 |
Acute phenibut withdrawal: A comprehensive literature review and illustrative case report.
Topics: Akathisia, Drug-Induced; Baclofen; Cyproheptadine; Dexmedetomidine; Diphenhydramine; GABA-A Receptor Antagonists; GABA-B Receptor Agonists; gamma-Aminobutyric Acid; Haloperidol; Humans; Lorazepam; Male; Melatonin; Neuroleptic Malignant Syndrome; Olanzapine; Receptors, GABA; Substance Withdrawal Syndrome; Substance-Related Disorders; Young Adult | 2019 |
The pharmacological management of agitated and aggressive behaviour: A systematic review and meta-analysis.
Topics: Aggression; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Haloperidol; Humans; Hypnotics and Sedatives; Lorazepam; Midazolam; Olanzapine; Promethazine; Psychomotor Agitation; Psychotic Disorders; Treatment Outcome | 2019 |
Association of Delirium Response and Safety of Pharmacological Interventions for the Management and Prevention of Delirium: A Network Meta-analysis.
Topics: Antipsychotic Agents; Delirium; Drug Therapy, Combination; Haloperidol; Humans; Indenes; Lorazepam; Network Meta-Analysis; Treatment Outcome | 2019 |
Cannabinoid hyperemesis syndrome: An unrecognized cause of nausea and vomiting.
Topics: Acute Disease; Antiemetics; Cannabinoids; Haloperidol; Humans; Lorazepam; Nausea; Syndrome; Vomiting | 2019 |
Drug therapy for delirium in terminally ill adults.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Delirium; Haloperidol; Humans; Lorazepam; Randomized Controlled Trials as Topic; Terminally Ill | 2020 |
Benzodiazepines for treatment of patients with delirium excluding those who are cared for in an intensive care unit.
Topics: Antipsychotic Agents; Benzodiazepines; Critical Care; Delirium; Haloperidol; Humans; Lorazepam; Palliative Care; Randomized Controlled Trials as Topic | 2020 |
Psychopharmacology of agitation in acute psychotic and manic episodes.
Topics: Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Haloperidol; Humans; Lorazepam; Mania; Olanzapine; Promethazine; Psychomotor Agitation; Psychopharmacology; Psychotic Disorders | 2022 |
32 trial(s) available for lorazepam and haloperidol
| Article | Year |
|---|---|
Haloperidol and lorazepam combined: clinical effects and drug plasma levels in the treatment of acute schizophrenic psychosis.
Topics: Acute Disease; Adult; Drug Therapy, Combination; Female; Haloperidol; Humans; Lorazepam; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1992 |
Adjunctive treatment of manic agitation with lorazepam versus haloperidol: a double-blind study.
Topics: Adult; Aged; Aggression; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Haloperidol; Humans; Lithium; Lorazepam; Male; Middle Aged; Psychiatric Status Rating Scales; Psychomotor Agitation | 1992 |
Parenteral lorazepam versus parenteral haloperidol for the control of psychotic disruptive behavior.
Topics: Acute Disease; Adult; Aggression; Antipsychotic Agents; Double-Blind Method; Drug Therapy, Combination; Haloperidol; Hospitalization; Humans; Injections, Intramuscular; Lorazepam; Prospective Studies; Psychotic Disorders | 1991 |
Efficacy of combinations of intramuscular antipsychotics and sedative-hypnotics for control of psychotic agitation.
Topics: Adolescent; Adult; Drug Combinations; Drug Therapy, Combination; Female; Haloperidol; Humans; Injections, Intramuscular; Lorazepam; Male; Middle Aged; Phenobarbital; Pilot Projects; Psychomotor Agitation; Psychotic Disorders; Randomized Controlled Trials as Topic; Thiothixene | 1989 |
The use of benzodiazepines in the treatment of manic-depressive illness.
Topics: Acute Disease; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Basal Ganglia Diseases; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Clonazepam; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Haloperidol; Humans; Lithium; Lorazepam; Parkinson Disease, Secondary; Random Allocation; Schizophrenia | 1988 |
Impairment of recall improves tolerance of cytotoxic chemotherapy.
Topics: Anti-Anxiety Agents; Antineoplastic Agents; Clinical Trials as Topic; Double-Blind Method; Drug Tolerance; Haloperidol; Humans; Lorazepam; Memory; Mental Recall; Vomiting | 1983 |
A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients.
Topics: Adult; AIDS Dementia Complex; Basal Ganglia Diseases; Chlorpromazine; Delirium; Double-Blind Method; Drug Administration Schedule; Female; Haloperidol; Hospitalization; Humans; Lorazepam; Male; Middle Aged; Prevalence; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome | 1996 |
Antipsychotic drug-induced dysphoria.
Topics: Adolescent; Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Depression; Double-Blind Method; Haloperidol; Humans; Lorazepam; Male | 1996 |
Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Antipsychotic Agents; Brief Psychiatric Rating Scale; Demography; Double-Blind Method; Drug Therapy, Combination; Emergency Medical Services; Female; Haloperidol; Humans; Lorazepam; Male; Middle Aged; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders | 1997 |
Efficacy of lorazepam and haloperidol for rapid tranquilization in a psychiatric emergency room setting.
Topics: Administration, Oral; Adolescent; Adult; Anti-Anxiety Agents; Antipsychotic Agents; Double-Blind Method; Emergency Medical Services; Female; Haloperidol; Humans; Injections, Intramuscular; Lorazepam; Male; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders | 1997 |
The effects of haloperidol on visual search, eye movements and psychomotor performance.
Topics: Adolescent; Adult; Attention; Cross-Over Studies; Dopamine Antagonists; Eye Movements; GABA Modulators; Haloperidol; Humans; Lorazepam; Male; Psychomotor Performance; Pursuit, Smooth; Saccades; Visual Perception | 1997 |
Acute mania: haloperidol dose and augmentation with lithium or lorazepam.
Topics: Adult; Aged; Anti-Anxiety Agents; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Citrates; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Haloperidol; Humans; Lorazepam; Middle Aged | 1999 |
Relationships between psychotropic drug dosage, plasma drug concentration, and prolactin levels in nursing home residents.
Topics: Aged; Aged, 80 and over; Anti-Anxiety Agents; Antipsychotic Agents; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Haloperidol; Humans; Lorazepam; Male; Nursing Homes; Placebos; Prolactin; Thioridazine; Tranquilizing Agents | 2000 |
The differential effects of chlorpromazine and haloperidol on latent inhibition in healthy volunteers.
Topics: Acoustic Stimulation; Adolescent; Adult; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Attention; Chlorpromazine; Cognition; Double-Blind Method; Haloperidol; Humans; Learning; Lorazepam; Male; Neuropsychological Tests; Paroxetine; Psychomotor Performance; Space Perception | 2001 |
Calming versus sedative effects of intramuscular olanzapine in agitated patients.
Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dementia; Double-Blind Method; Drug Administration Schedule; Haloperidol; Humans; Hypnotics and Sedatives; Injections, Intramuscular; Lorazepam; Olanzapine; Pirenzepine; Psychomotor Agitation; Retrospective Studies; Schizophrenia; Treatment Outcome | 2003 |
Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Antipsychotic Agents; Cluster Analysis; Drug Therapy, Combination; Female; Haloperidol; Humans; Injections, Intramuscular; Lorazepam; Male; Middle Aged; Prospective Studies; Psychomotor Agitation; Risperidone; Severity of Illness Index; Single-Blind Method | 2004 |
Efficacy of accelerated dose titration of olanzapine with adjunctive lorazepam to treat acute agitation in schizophrenia.
Topics: Acute Disease; Administration, Oral; Adult; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Emergency Services, Psychiatric; Emergency Treatment; Female; Haloperidol; Humans; Lorazepam; Male; Olanzapine; Prospective Studies; Psychomotor Agitation; Schizophrenia; Severity of Illness Index; Treatment Outcome | 2004 |
A prospective, double-blind, randomized trial of midazolam versus haloperidol versus lorazepam in the chemical restraint of violent and severely agitated patients.
Topics: Adult; Arousal; Blood Pressure; Double-Blind Method; Haloperidol; Heart Rate; Humans; Lorazepam; Midazolam; Prospective Studies; Psychomotor Agitation; Respiratory Mechanics; Tranquilizing Agents; Treatment Outcome; Violence | 2004 |
Rapid tranquillisation of violent or agitated patients in a psychiatric emergency setting. Pragmatic randomised trial of intramuscular lorazepam v. haloperidol plus promethazine.
Topics: Antipsychotic Agents; Drug Therapy, Combination; Emergencies; Emergency Service, Hospital; Female; Haloperidol; Histamine H1 Antagonists; Humans; Hypnotics and Sedatives; Lorazepam; Male; Mental Disorders; Promethazine; Psychomotor Agitation; Time Factors; Violence | 2004 |
Intramuscular haloperidol or lorazepam and QT intervals in schizophrenia.
Topics: Adult; Confidence Intervals; Cross-Over Studies; Electrocardiography; Female; Haloperidol; Humans; Injections, Intramuscular; Long QT Syndrome; Lorazepam; Male; Middle Aged; Schizophrenia | 2004 |
Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Bipolar Disorder; Dopamine Antagonists; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Haloperidol; Humans; Lorazepam; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Risperidone; Serotonin Antagonists; Time Factors; Treatment Outcome | 2005 |
Risperidone versus haloperidol, in combination with lorazepam, in the treatment of acute agitation and psychosis: a pilot, randomized, double-blind, placebo-controlled trial.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Anxiety Agents; Antipsychotic Agents; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Haloperidol; Humans; Lorazepam; Male; Middle Aged; Pilot Projects; Prospective Studies; Psychomotor Agitation; Risperidone; Severity of Illness Index; Treatment Outcome | 2006 |
The role of sedation tests in identifying sedative drug effects in healthy volunteers and their power to dissociate sedative-related impairments from memory dysfunctions.
Topics: Adult; Affect; Antipsychotic Agents; Arousal; Benzodiazepines; Choice Behavior; Cross-Over Studies; Double-Blind Method; Female; Haloperidol; Histamine H1 Antagonists; Humans; Hypnotics and Sedatives; Lorazepam; Male; Memory; Memory Disorders; Mianserin; Mirtazapine; Olanzapine; Psychological Tests; Psychomotor Performance; Reaction Time; Reference Values; Saccades; Surveys and Questionnaires; Verbal Learning | 2007 |
Efficacy of sodium valproate and haloperidol in the management of acute mania: a randomized open-label comparative study.
Topics: Adolescent; Adult; Antimanic Agents; Bipolar Disorder; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Injections, Intramuscular; Injections, Intravenous; Lorazepam; Male; Middle Aged; Severity of Illness Index; Valproic Acid | 2010 |
A randomized trial of the effectiveness of topical "ABH Gel" (Ativan(®), Benadryl(®), Haldol(®)) vs. placebo in cancer patients with nausea.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antiemetics; Cross-Over Studies; Diphenhydramine; Double-Blind Method; Drug Combinations; Female; Gels; Haloperidol; Humans; Lorazepam; Male; Middle Aged; Nausea; Neoplasms; Treatment Outcome; Vomiting; Young Adult | 2014 |
Intramuscular olanzapine versus intramuscular haloperidol plus lorazepam for the treatment of acute schizophrenia with agitation: An open-label, randomized controlled trial.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Female; Haloperidol; Humans; Injections, Intramuscular; Lorazepam; Male; Middle Aged; Olanzapine; Prospective Studies; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Schizophrenia; Taiwan; Treatment Outcome | 2015 |
Prevalence, risk factors, and outcomes associated with physical restraint use in mechanically ventilated adults.
Topics: Adult; Aged; Alcohol Drinking; Analgesics, Opioid; Antipsychotic Agents; Benzodiazepines; Clinical Protocols; Device Removal; Female; Fentanyl; Haloperidol; Humans; Hydromorphone; Intensive Care Units; Lorazepam; Male; Midazolam; Middle Aged; Morphine; Multivariate Analysis; Prevalence; Proportional Hazards Models; Respiration, Artificial; Restraint, Physical; Risk Factors; Ventilators, Mechanical | 2016 |
Effect of Lorazepam With Haloperidol vs Haloperidol Alone on Agitated Delirium in Patients With Advanced Cancer Receiving Palliative Care: A Randomized Clinical Trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Double-Blind Method; Drug Therapy, Combination; Female; Haloperidol; Hospitalization; Humans; Lorazepam; Male; Middle Aged; Neoplasms; Palliative Care | 2017 |
The minimal clinically important difference of the Richmond Agitation-Sedation Scale in patients with cancer with agitated delirium.
Topics: Adult; Aged; Aged, 80 and over; Delirium; Drug Therapy, Combination; Female; Haloperidol; Humans; Lorazepam; Male; Middle Aged; Minimal Clinically Important Difference; Neoplasms; Palliative Care; Prospective Studies; Psychometrics; Psychomotor Agitation; Tranquilizing Agents | 2018 |
Lorazepam Added to Haloperidol Effective for Agitated Delirium in End-of-Life Cancer Patients.
Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Delirium; Drug Therapy, Combination; Female; Haloperidol; Humans; Lorazepam; Male; Middle Aged; Neoplasms; Terminal Care | 2018 |
Efficacy of ketamine for initial control of acute agitation in the emergency department: A randomized study.
Topics: Adult; Aged; Aged, 80 and over; Anesthetics, Dissociative; Anti-Anxiety Agents; Antipsychotic Agents; Emergency Service, Hospital; Female; Haloperidol; Humans; Ketamine; Lorazepam; Male; Middle Aged; Pilot Projects; Prospective Studies; Psychomotor Agitation; United States | 2021 |
Association among rescue neuroleptic use, agitation, and perceived comfort: secondary analysis of a randomized clinical trial on agitated delirium.
Topics: Antipsychotic Agents; Delirium; Double-Blind Method; Haloperidol; Humans; Lorazepam; Psychomotor Agitation | 2021 |
106 other study(ies) available for lorazepam and haloperidol
| Article | Year |
|---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Management of the elderly agitated demented patient.
Topics: Aged; Anti-Anxiety Agents; Dementia; Drug Combinations; Haloperidol; Humans; Lorazepam; Trihexyphenidyl | 1977 |
ECT response in catatonia.
Topics: Electroconvulsive Therapy; Functional Laterality; Haloperidol; Humans; Lorazepam; Male; Schizophrenia, Catatonic | 1992 |
Neuroleptic malignant syndrome (a case report).
Topics: Adult; Bromocriptine; Female; Haloperidol; Humans; Lorazepam; Neuroleptic Malignant Syndrome | 1991 |
Psychogenic catatonia with elevated creatine kinase and autonomic hyperactivity.
Topics: Adult; Arousal; Autonomic Nervous System; Catatonia; Combined Modality Therapy; Creatine Kinase; Delusions; Diagnosis, Differential; Electroconvulsive Therapy; Haloperidol; Humans; Lorazepam; Male; Neuroleptic Malignant Syndrome; Psychophysiologic Disorders | 1991 |
Compounding nausea aid.
Topics: Benztropine; Chemistry, Pharmaceutical; Dexamethasone; Diphenhydramine; Drug Combinations; Drug Compounding; Haloperidol; Humans; Lorazepam; Metoclopramide; Nausea; Suppositories; Vomiting | 1991 |
Emergency intravenous sedation of the delirious, medically ill patient.
Topics: Critical Care; Delirium; Drug Therapy, Combination; Haloperidol; Humans; Hydromorphone; Infusions, Intravenous; Injections, Intravenous; Lorazepam; Multiple Organ Failure; Neoplasms; Pain, Intractable; Palliative Care | 1988 |
Haloperidol-induced neuroleptic malignant syndrome in a 67-year-old woman with parkinsonism.
Topics: Aged; Female; Haloperidol; Humans; Lorazepam; Neuroleptic Malignant Syndrome; Parkinson Disease | 1989 |
Haloperidol and lorazepam for the treatment of nausea and vomiting associated with the treatment of intractable migraine headaches.
Topics: Adult; Dihydroergotamine; Female; Haloperidol; Humans; Lorazepam; Migraine Disorders; Nausea; Vomiting | 1989 |
Modification of visual orientation illusions by drugs which influence dopamine and GABA neurones: differential effects on simultaneous and successive illusions.
Topics: Adolescent; Adult; Dopamine; Female; gamma-Aminobutyric Acid; Haloperidol; Humans; Illusions; Lorazepam; Male; Maprotiline; Neurons; Nomifensine; Optical Illusions; Orientation | 1986 |
New pharmacologic approaches in the treatment of psychosis. Proceedings of a symposium. Philadelphia, June 29, 1985.
Topics: Haloperidol; Humans; Lorazepam; Psychotic Disorders | 1986 |
Benzodiazepines combined with neuroleptics for management of severe disruptive behavior.
Topics: Adolescent; Adult; Aged; Dangerous Behavior; Drug Therapy, Combination; Female; Haloperidol; Hospitals, Psychiatric; Humans; Injections, Intramuscular; Lorazepam; Male; Middle Aged; Psychomotor Agitation; Violence | 1986 |
Alternative approaches in the treatment of psychotic agitation.
Topics: Combined Modality Therapy; Haloperidol; Humans; Injections, Intramuscular; Lorazepam; Psychomotor Agitation; Psychotic Disorders | 1986 |
Emergency pharmacotherapy of delirium in the critically ill cancer patient.
Topics: Adult; Aged; Delirium; Drug Therapy, Combination; Emergencies; Female; Haloperidol; Humans; Infusions, Parenteral; Lorazepam; Male; Middle Aged; Neoplasms; Neurocognitive Disorders | 1986 |
Emergency treatment of acute psychosis, agitation, and anxiety.
Topics: Anxiety Disorders; Diazepam; Droperidol; Emergencies; Haloperidol; Humans; Lorazepam; Panic; Propranolol; Psychomotor Agitation; Psychotic Disorders; Psychotropic Drugs | 1985 |
Lorazepam as an adjunct to antiemetic therapy with haloperidol in patients receiving cytotoxic chemotherapy.
Topics: Anti-Anxiety Agents; Antiemetics; Antineoplastic Agents; Drug Therapy, Combination; Female; Haloperidol; Humans; Lorazepam; Male; Nausea; Pilot Projects; Vomiting | 1983 |
Intravenous lorazepam in neuroleptic-induced catatonia.
Topics: Adult; Aged; Antipsychotic Agents; Catatonia; Female; Haloperidol; Humans; Injections, Intravenous; Lorazepam; Male; Syndrome; Trifluoperazine | 1983 |
Extrapyramidal side effects and oral haloperidol: an analysis of explanatory patient and treatment characteristics.
Topics: Adolescent; Adult; Age Factors; Aged; Antiparkinson Agents; Basal Ganglia Diseases; Drug Therapy, Combination; Female; Haloperidol; Humans; Lorazepam; Male; Mental Disorders; Middle Aged; Parkinson Disease, Secondary | 1982 |
Delusional electronic dental implant: case reports and literature review.
Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Delusions; Dental Implants; Drug Therapy, Combination; Electronics; Haloperidol; Humans; Lorazepam; Loxapine; Male; Middle Aged | 1995 |
Steroid-induced psychosis: report of case.
Topics: Dexamethasone; Edema; Haloperidol; Humans; Lorazepam; Male; Maxilla; Middle Aged; Osteotomy; Perphenazine; Psychoses, Substance-Induced | 1995 |
Pitfalls in the treatment of jimsonweed intoxication.
Topics: Adolescent; Contraindications; Datura stramonium; Drug Therapy, Combination; Haloperidol; Humans; Lorazepam; Male; Physostigmine; Plants, Medicinal; Plants, Toxic; Psychoses, Substance-Induced; Substance-Related Disorders | 1994 |
Treatment of catatonic stupor with oral lorazepam in 14-year-old psychotic boy.
Topics: Adolescent; Catatonia; Haloperidol; Humans; Lorazepam; Male; Psychotic Disorders | 1993 |
Acute manic episodes in pregnancy.
Topics: Adult; Bipolar Disorder; Chlorpromazine; Comorbidity; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Electroconvulsive Therapy; Female; Haloperidol; Humans; Lorazepam; Pregnancy; Pregnancy Complications; Valproic Acid | 1996 |
Increase of serum creatine phosphokinase in catatonia: an investigation in 32 acute catatonic patients.
Topics: Acute Disease; Adult; Antipsychotic Agents; Catatonia; Combined Modality Therapy; Creatine Kinase; Diagnosis, Differential; Dyskinesia, Drug-Induced; Electroconvulsive Therapy; Female; Haloperidol; Humans; Hypnotics and Sedatives; Lorazepam; Male; Middle Aged; Neurologic Examination; Parkinson Disease, Secondary; Reference Values; Schizophrenia, Catatonic | 1996 |
Bipolar disorder following a stroke involving the left hemisphere.
Topics: Bipolar Disorder; Cerebral Infarction; Dominance, Cerebral; Drug Therapy, Combination; Haloperidol; Humans; Lorazepam; Magnetic Resonance Imaging; Male; Middle Aged; Neurocognitive Disorders; Neurologic Examination | 1996 |
Effect of ethanol, haloperidol, and lorazepam on cardiac conduction and contraction.
Topics: Alcoholic Intoxication; Animals; Antipsychotic Agents; Central Nervous System Depressants; Dose-Response Relationship, Drug; Drug Interactions; Electrophysiology; Ethanol; Haloperidol; Heart Conduction System; Hypnotics and Sedatives; Lorazepam; Male; Myocardial Contraction; Rats; Rats, Sprague-Dawley | 1996 |
Steroid psychosis after orthognathic surgery: a case report.
Topics: Adult; Anti-Inflammatory Agents; Antipsychotic Agents; Delirium; Delusions; Dexamethasone; Haloperidol; Humans; Hypnotics and Sedatives; Lorazepam; Male; Mandible; Maxilla; Osteotomy; Paranoid Disorders; Psychoses, Substance-Induced | 1997 |
Catatonia in an adolescent with Prader-Willi Syndrome.
Topics: Adolescent; Antipsychotic Agents; Catatonia; Haloperidol; Humans; Lorazepam; Male; Neurologic Examination; Neuropsychological Tests; Prader-Willi Syndrome; Risperidone; Treatment Outcome | 1997 |
The antiemetic efficacy of granisetron plus dexamethasone, haloperidol and loracepam in breast cancer patients treated with high-dose chemotherapy with peripheral blood stem-cell support.
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Dexamethasone; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Granisetron; Haloperidol; Hematopoietic Stem Cell Transplantation; Humans; Lorazepam; Middle Aged; Nausea; Palliative Care; Treatment Outcome; Vomiting | 1998 |
Frequency, severity, and treatment of agitation in young versus elderly patients in the ICU.
Topics: Adult; Age Factors; Aged; Analgesics, Opioid; Anti-Anxiety Agents; Antipsychotic Agents; APACHE; Cohort Studies; Drug Administration Schedule; Female; Haloperidol; Humans; Intensive Care Units; Length of Stay; Lorazepam; Male; Middle Aged; Morphine; Prospective Studies; Psychomotor Agitation; Tranquilizing Agents | 2000 |
Evaluating the usage of droperidol in acutely agitated persons with brain injury.
Topics: Adult; Antipsychotic Agents; Brain Injuries; Diphenhydramine; Droperidol; Female; Haloperidol; Humans; Hypnotics and Sedatives; Injections, Intramuscular; Lorazepam; Male; Prospective Studies; Psychomotor Agitation; Treatment Outcome | 2000 |
Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation.
Topics: Acute Disease; Administration, Oral; Adult; Antipsychotic Agents; Drug Therapy, Combination; Emergency Services, Psychiatric; Female; Haloperidol; Humans; Hypnotics and Sedatives; Injections, Intramuscular; Lorazepam; Male; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Risperidone; Treatment Outcome; Violence | 2001 |
Lack of efficacy of benzodiazepines in treating gamma-hydroxybutyrate withdrawal.
Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Haloperidol; Humans; Lorazepam; Male; Sodium Oxybate; Substance Withdrawal Syndrome | 2001 |
Failed challenge with quetiapine after neuroleptic malignant syndrome with conventional antipsychotics.
Topics: Alzheimer Disease; Antipsychotic Agents; Chlorpromazine; Dibenzothiazepines; Haloperidol; Humans; Hyperthyroidism; Lorazepam; Male; Middle Aged; Neuroleptic Malignant Syndrome; Psychomotor Agitation; Quetiapine Fumarate | 2001 |
Cells in midline thalamus, central amygdala, and nucleus accumbens responding specifically to antipsychotic drugs.
Topics: Amygdala; Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Diphenhydramine; Haloperidol; Immunohistochemistry; Injections, Intraperitoneal; Lorazepam; Male; Midline Thalamic Nuclei; Nucleus Accumbens; Olanzapine; Pirenzepine; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley | 2003 |
Impact of an alcohol withdrawal syndrome practice guideline on surgical patient outcomes.
Topics: Adolescent; Adult; Aged; Alcohol-Related Disorders; Clonidine; Ethanol; Female; Haloperidol; Humans; Length of Stay; Lorazepam; Male; Middle Aged; Pilot Projects; Postoperative Complications; Practice Guidelines as Topic; Prospective Studies; Restraint, Physical; Retrospective Studies; Severity of Illness Index; Substance Withdrawal Syndrome; Surgical Procedures, Operative | 2003 |
Clinical case presentation: therapeutic challenges in adolescent-onset bipolar disorder.
Topics: Adolescent; Aggression; Anti-Anxiety Agents; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Clonazepam; Diagnosis, Differential; Education; Family; GABA Modulators; Haloperidol; Hospitalization; Humans; Irritable Mood; Lithium; Lorazepam; Male; Piperazines; Psychiatric Status Rating Scales; Sexual Behavior; Thiazoles; Valproic Acid | 2003 |
Challenges in palliative care research: one experience.
Topics: Antiemetics; Attitude of Health Personnel; Diphenhydramine; Drug Combinations; Ethics Committees, Research; Haloperidol; Hospice Care; Humans; Lorazepam; Metoclopramide; Nausea; Palliative Care; Patient Selection; Randomized Controlled Trials as Topic | 2004 |
Persistent psychotic disorder in an adolescent with a past history of butane gas dependence.
Topics: Adolescent; Antipsychotic Agents; Butanes; Diagnostic and Statistical Manual of Mental Disorders; Haloperidol; Humans; Lorazepam; Male; Psychotic Disorders; Substance-Related Disorders; Time Factors | 2004 |
Delirium in the older hospitalized patient.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Confusion; Delirium; Glasgow Coma Scale; Haloperidol; Hospital Units; Humans; Inpatients; Lorazepam; Psychiatric Status Rating Scales; Restraint, Physical | 2005 |
Limitations of rapid tranquillisation trial.
Topics: Antipsychotic Agents; Central Nervous System Depressants; Drug Therapy, Combination; Haloperidol; Humans; Hypnotics and Sedatives; Lorazepam; Mental Disorders; Promethazine; Treatment Outcome | 2005 |
Drug combinations for rapid tranquillisation.
Topics: Antipsychotic Agents; Central Nervous System Depressants; Cost-Benefit Analysis; Drug Therapy, Combination; Haloperidol; Humans; Hypnotics and Sedatives; Lorazepam; Promethazine | 2005 |
Neuroleptic malignant syndrome precipitated by haloperidol following clozapine discontinuation.
Topics: Adult; Anti-Anxiety Agents; Antiparkinson Agents; Antipsychotic Agents; Bromocriptine; Clozapine; Creatine Kinase; Dose-Response Relationship, Drug; Electroconvulsive Therapy; Haloperidol; Humans; Lorazepam; Male; Neuroleptic Malignant Syndrome; Psychotic Disorders; Schizophrenia; Substance Withdrawal Syndrome | 2005 |
Experience with an adult alcohol withdrawal syndrome practice guideline in internal medicine patients.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Alcohol Withdrawal Delirium; Anti-Anxiety Agents; Antipsychotic Agents; Clonidine; Female; Haloperidol; Hospitals, Teaching; Humans; Internal Medicine; Length of Stay; Lorazepam; Male; Middle Aged; Pilot Projects; Practice Guidelines as Topic; Restraint, Physical; Retrospective Studies; Treatment Outcome | 2005 |
Tolerability of the compound ABHR in hospice patients.
Topics: Aged; Antiemetics; Cohort Studies; Diphenhydramine; Drug Combinations; Female; Haloperidol; Hospice Care; Humans; Lorazepam; Male; Metoclopramide; Nausea; Retrospective Studies; United States; Vomiting | 2005 |
An unusual case of subterfuge in the emergency department: covert administration of antipsychotic and anxiolytic medications to control an agitated patient.
Topics: Administration, Oral; Adult; Anti-Anxiety Agents; Antipsychotic Agents; Beverages; Bipolar Disorder; California; Drug Utilization; Emergency Services, Psychiatric; Haloperidol; Humans; Informed Consent; Lorazepam; Male; Psychomotor Agitation; Risk Management; Treatment Refusal | 2006 |
Naturalistic study of intramuscular ziprasidone versus conventional agents in agitated elderly patients: retrospective findings from a psychiatric emergency service.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Databases, Factual; Emergency Medical Services; Emergency Service, Hospital; Female; Haloperidol; Humans; Hypnotics and Sedatives; Injections, Intramuscular; Lorazepam; Male; Piperazines; Psychomotor Agitation; Retrospective Studies; Thiazoles; Treatment Outcome | 2005 |
Compliance of an institution-specific alcohol withdrawal protocol with evidence-based practice guidelines.
Topics: Adrenergic alpha-Agonists; Adult; Anti-Anxiety Agents; Antipsychotic Agents; Clonidine; Ethanol; Evidence-Based Medicine; Haloperidol; Humans; Lorazepam; Practice Guidelines as Topic; Substance Withdrawal Syndrome | 2006 |
Perioperative haloperidol to prevent postoperative delirium.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Delirium; Dose-Response Relationship, Drug; Drug Therapy, Combination; Haloperidol; Humans; Lorazepam; Perioperative Care; Postoperative Complications | 2006 |
[Hemiballism-hemichorea syndrome].
Topics: Anti-Dyskinesia Agents; Brain Diseases; Cerebrovascular Circulation; Chorea; Drug Therapy, Combination; Dyskinesias; Follow-Up Studies; Glycated Hemoglobin; Haloperidol; Humans; Hyperglycemia; Lorazepam; Magnetic Resonance Imaging; Male; Middle Aged; Putamen; Syndrome; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Anticholinergic drug-induced delirium in an elderly Alzheimer's dementia patient.
Topics: Acute Disease; Aged, 80 and over; Alzheimer Disease; Amitriptyline; Antipsychotic Agents; Cholinergic Antagonists; Delirium; Depressive Disorder, Major; Drug Therapy, Combination; GABA Modulators; Haloperidol; Humans; Lorazepam; Male; Orphenadrine | 2007 |
Intramuscular aripiprazole in the control of agitation.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Arousal; Bipolar Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Haloperidol; Humans; Hypnotics and Sedatives; Injections, Intramuscular; Lorazepam; Male; Middle Aged; Multicenter Studies as Topic; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Quinolones; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2007 |
Teenagers with Jimson weed (Datura stramonium) poisoning.
Topics: Adolescent; Anti-Anxiety Agents; Antipsychotic Agents; Cholinergic Antagonists; Confusion; Datura stramonium; Female; Hallucinations; Haloperidol; Humans; Lorazepam; Male; Poisoning; Pupil Disorders; Restraint, Physical; Seeds; Speech Intelligibility | 2007 |
Maximal response to electroconvulsive therapy for the treatment of catatonic symptoms.
Topics: Administration, Oral; Adult; Aged; Antipsychotic Agents; Catatonia; Diazepam; Dose-Response Relationship, Drug; Electroconvulsive Therapy; Female; Haloperidol; Humans; Hypnotics and Sedatives; Infusions, Intravenous; Lorazepam; Male; Middle Aged; Retreatment; Risperidone; Schizophrenia, Catatonic; Treatment Outcome | 2007 |
Multiple medication use presenting as Parkinson's dementia complex: a message from Titanic.
Topics: Aged; Anti-Infective Agents; Antiparkinson Agents; Antipsychotic Agents; Bacteriuria; Ciprofloxacin; Dementia; Drug Interactions; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Fluoxetine; Haloperidol; Hospitalization; Humans; Hypnotics and Sedatives; Lorazepam; Parkinson Disease; Psychomotor Agitation; Selegiline; Trihexyphenidyl | 2008 |
Lorazepam, diphenhydramine, and haloperidol transdermal gel for rescue from chemotherapy-induced nausea/vomiting: results of two pilot trials.
Topics: Administration, Cutaneous; Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Diphenhydramine; Drug Delivery Systems; Gels; Haloperidol; Humans; Lorazepam; Nausea; Neoplasms; Pilot Projects; Skin; Surveys and Questionnaires; Vomiting | 2008 |
Fasciculations after rattlesnake envenomations: a retrospective statewide poison control system study.
Topics: Adolescent; Adult; Animals; Antivenins; Anxiety; California; Child; Child, Preschool; Crotalus; Databases, Factual; Diazepam; Fasciculation; Female; Haloperidol; Humans; Lorazepam; Male; Middle Aged; Myokymia; Poison Control Centers; Psychomotor Agitation; Retrospective Studies; Seasons; Snake Bites | 2008 |
Efficacy of imipramine in psychotic versus nonpsychotic depression.
Topics: Adult; Affective Disorders, Psychotic; Aged; Antidepressive Agents; Data Interpretation, Statistical; Depressive Disorder; Desipramine; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Drug Therapy, Combination; Female; Haloperidol; Humans; Imipramine; Logistic Models; Lorazepam; Male; Middle Aged; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome | 2008 |
Treatment of postpartum depression with psychotic features in a patient with tropical spastic paraparesis.
Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Benztropine; Clonidine; Depression, Postpartum; Female; Haiti; Haloperidol; Humans; Lorazepam; Paraparesis, Tropical Spastic; Parasympatholytics; Sertraline | 2008 |
Case of acute psychosis from herbal supplements.
Topics: Acute Disease; Adult; Antipsychotic Agents; Dietary Supplements; Female; Haloperidol; Humans; Lorazepam; Plant Extracts; Psychoses, Substance-Induced; Risperidone; Treatment Outcome | 2008 |
Hemiballismus in subthalamic haemorrhage: efficacy of levetiracetam.
Topics: Aged; Anti-Dyskinesia Agents; Anticonvulsants; Antihypertensive Agents; Ataxia; Cerebellum; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyskinesias; Haloperidol; Hemangioma, Cavernous, Central Nervous System; Humans; Hypertension; Intracranial Hemorrhage, Hypertensive; Levetiracetam; Lorazepam; Magnetic Resonance Imaging; Male; Piracetam; Recurrence; Subthalamic Nucleus; Treatment Outcome; Vomiting | 2009 |
Fatal pulmonary embolism following antipsychotic treatment and physical restraint.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Fatal Outcome; Female; Haloperidol; Heart Arrest; Heart Failure; Humans; Hypnotics and Sedatives; Lorazepam; Olanzapine; Practice Guidelines as Topic; Pulmonary Artery; Pulmonary Embolism; Restraint, Physical; Schizophrenia, Paranoid; Venous Thromboembolism | 2009 |
Psychiatrist accused of dishonesty for prescribing drugs to a patient under a false name.
Topics: Antipsychotic Agents; Deception; England; Female; Haloperidol; Humans; Lorazepam; Prescription Drugs; Professional Misconduct; Psychiatry; Schizophrenia; Young Adult | 2010 |
An intoxicated man with facial trauma.
Topics: Aggression; Alcoholic Intoxication; Anti-Anxiety Agents; Antipsychotic Agents; Emergency Medical Services; Facial Injuries; Haloperidol; Humans; Hypnotics and Sedatives; Lorazepam; Male; Middle Aged; Psychomotor Agitation | 2010 |
Unusual presentation of a patient with GBL withdrawal: a case report.
Topics: 4-Butyrolactone; Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Chlorpromazine; Delirium; Hallucinations; Haloperidol; Humans; Hypnotics and Sedatives; Illicit Drugs; Lorazepam; Male; Substance Withdrawal Syndrome | 2011 |
Neuroleptic-induced catatonia in two hospitalized patients.
Topics: Adult; Antipsychotic Agents; Dopamine D2 Receptor Antagonists; Female; Haloperidol; Hospitalization; Humans; Lorazepam; Male; Middle Aged; Muscle Rigidity; Psychotic Disorders; Receptors, Dopamine D2; Syndrome | 2012 |
ABH gel is not absorbed from the skin of normal volunteers.
Topics: Absorption; Administration, Cutaneous; Adult; Antiemetics; Diphenhydramine; Female; Haloperidol; Humans; Lorazepam; Male; Middle Aged; Skin | 2012 |
Delayed onset and prolonged interictal delirium following electroconvulsive therapy.
Topics: Cholinesterase Inhibitors; Delirium; Depressive Disorder; Donepezil; Electroconvulsive Therapy; Follow-Up Studies; Haloperidol; Humans; Hypnotics and Sedatives; Indans; Lorazepam; Male; Middle Aged; Piperidines; Risk Factors; Time Factors | 2012 |
Psychotic disorder after contact with a potentially rabid animal and post-exposure prophylactic anti-rabies treatment.
Topics: Adult; Anti-Anxiety Agents; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Clonazepam; Diagnosis, Differential; Dibenzothiazepines; Female; Haloperidol; Humans; Lorazepam; Olanzapine; Psychotic Disorders; Quetiapine Fumarate; Rabies; Rabies Vaccines; Young Adult | 2014 |
Haloperidol overdosing in the treatment of agitated hospitalized older people with delirium: a retrospective chart review from a community teaching hospital.
Topics: Aged; Aged, 80 and over; Aging; Anti-Anxiety Agents; Delirium; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Prescriptions; Drug Therapy, Combination; Female; GABA Modulators; Haloperidol; Hospitals, Community; Hospitals, Teaching; Humans; Length of Stay; Lorazepam; Male; Medical Records; Pennsylvania; Practice Patterns, Physicians'; Psychomotor Agitation; Retrospective Studies | 2013 |
Stability of intraocular pressure after retinal reattachment surgery during electroconvulsive therapy for intractable self-injury in a 12-year-old autistic boy.
Topics: Aggression; Anticonvulsants; Antipsychotic Agents; Autistic Disorder; Child; Electroconvulsive Therapy; Flumazenil; GABA Modulators; Haloperidol; Humans; Hypnotics and Sedatives; Intraocular Pressure; Lorazepam; Male; Ophthalmologic Surgical Procedures; Psychomotor Agitation; Retinal Detachment; Self-Injurious Behavior | 2014 |
Patterns of opiate, benzodiazepine, and antipsychotic drug dosing in older patients in a medical intensive care unit.
Topics: Aged; Analgesics, Opioid; Antipsychotic Agents; Bayes Theorem; Benzodiazepines; Cohort Studies; Connecticut; Delirium; Female; Fentanyl; Haloperidol; Humans; Hypnotics and Sedatives; Intensive Care Units; Lorazepam; Male; Middle Aged | 2013 |
Propofol for benzodiazepine-refractory alcohol withdrawal in a non-mechanically ventilated patient.
Topics: Adult; Alcohol Withdrawal Delirium; Diazepam; Emergency Service, Hospital; Haloperidol; Humans; Hypnotics and Sedatives; Lorazepam; Male; Propofol; Treatment Failure | 2014 |
[QTc prolongation induced by intravenous sedation with Haloperidol, Prothipendyl and Lorazepam].
Topics: Adult; Age Factors; Aged; Comorbidity; Conscious Sedation; Drug Synergism; Drug Therapy, Combination; Female; Haloperidol; Humans; Infusions, Intravenous; Long QT Syndrome; Lorazepam; Male; Middle Aged; Psychotic Disorders; Thiazines | 2014 |
[Dermatozoic delirium: about a case].
Topics: Aged; Antidepressive Agents; Antipsychotic Agents; Cataract; Delusional Parasitosis; Diabetes Complications; Diabetic Retinopathy; Haloperidol; Humans; Lorazepam; Male | 2013 |
Comfort care kit: use of nonoral and nonparenteral rescue medications at home for terminally ill patients with swallowing difficulty.
Topics: Acetaminophen; Adjuvants, Anesthesia; Administration, Rectal; Administration, Sublingual; Adult; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-Anxiety Agents; Antipsychotic Agents; Atropine; Caregivers; Deglutition Disorders; Female; Haloperidol; Home Care Services; Humans; Lorazepam; Male; Middle Aged; Morphine; Palliative Care; Pilot Projects; Singapore; Terminally Ill | 2014 |
A young woman presenting with psychotic and mood symptoms from anti-N-methyl-D-aspartate receptor (NMDA-R) encephalitis: an emerging diagnosis.
Topics: Adult; Affective Disorders, Psychotic; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Antibodies, Monoclonal, Murine-Derived; Anticonvulsants; Antipsychotic Agents; Diagnosis, Differential; Dibenzothiazepines; Electroencephalography; Female; Follow-Up Studies; Haloperidol; Humans; Immunologic Factors; Lorazepam; Phenytoin; Plasmapheresis; Quetiapine Fumarate; Rituximab; Treatment Outcome; Young Adult | 2013 |
Discontinuing the Use of PRN Intramuscular Medication for Agitation in an Acute Psychiatric Hospital.
Topics: Administration, Oral; Adult; Diphenhydramine; Drug Utilization; Female; Haloperidol; Hospitals, Psychiatric; Humans; Injections, Intramuscular; Lorazepam; Male; Middle Aged; Patient Safety; Psychomotor Agitation; Retrospective Studies; Young Adult | 2016 |
Look again at psychedelic drugs.
Topics: Anxiety; Delirium; Depression; Diazepam; Hallucinogens; Haloperidol; Humans; Lorazepam; Midazolam; Pharmaceutical Research; Psychomotor Agitation; United Kingdom | 2016 |
Severe Carisoprodol Withdrawal After a 14-Year Addiction and Acute Overdose.
Topics: Adult; Carisoprodol; Dexmedetomidine; Drug Overdose; Fentanyl; Haloperidol; Humans; Hypnotics and Sedatives; Intensive Care Units; Ketamine; Lorazepam; Male; Midazolam; Propofol; Quetiapine Fumarate; Respiration, Artificial; Substance Withdrawal Syndrome; Substance-Related Disorders | 2017 |
Lorazepam precipitated alcohol withdrawal delirium - Two case report.
Topics: Alcohol Withdrawal Delirium; Antipsychotic Agents; Drug Administration Schedule; Female; GABA Modulators; Haloperidol; Humans; Lorazepam; Male; Middle Aged | 2017 |
Two unusual cases of protracted inter-ictal delirium following electroconvulsive therapy.
Topics: Adult; Antipsychotic Agents; Delirium; Electroconvulsive Therapy; Haloperidol; Humans; Lorazepam; Male; Middle Aged; Schizophrenia; Time | 2017 |
Spontaneous recovery of traumatic brain injury-induced functional deficits is not hindered by daily administration of lorazepam.
Topics: Animals; Antipsychotic Agents; Brain Injuries, Traumatic; Cognition; Conditioning, Psychological; Disease Models, Animal; Haloperidol; Lorazepam; Male; Motor Activity; Rats, Sprague-Dawley; Recovery of Function | 2018 |
Meditation induced psychosis: Case report.
Topics: Adult; Antipsychotic Agents; GABA Modulators; Haloperidol; Humans; Lorazepam; Male; Meditation; Promethazine; Psychotic Disorders; Risperidone | 2018 |
Prolonged toxicity from Kambo cleansing ritual.
Topics: Adult; Animals; Anti-Allergic Agents; Anti-Anxiety Agents; Antipsychotic Agents; Anura; Ceremonial Behavior; Diphenhydramine; Female; Haloperidol; Humans; Lorazepam; Neuropeptides; Neurotoxicity Syndromes; Treatment Outcome; Young Adult | 2018 |
Study Enrollment When "Preconsent" Is Utilized for a Randomized Clinical Trial of Two Treatments for Acute Agitation in the Emergency Department.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Emergency Service, Hospital; Ethics, Research; Female; Haloperidol; Humans; Informed Consent; Lorazepam; Loxapine; Male; Middle Aged; Patient Selection; Psychomotor Agitation; Randomized Controlled Trials as Topic; Schizophrenia | 2019 |
Cycloid psychosis and its longitudinal diagnosis: case report.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Female; Haloperidol; Humans; Hypnotics and Sedatives; Lorazepam; Psychotic Disorders; Recurrence; Risperidone; Sertraline; Sleep Initiation and Maintenance Disorders | 2020 |
Overcoming Complications in Management of a Difficult-to-Treat Adolescent with Schizoaffective Disorder.
Topics: Adolescent; Adolescent Psychiatry; Antidepressive Agents; Antipsychotic Agents; Diphenhydramine; Female; Haloperidol; Humans; Hypnotics and Sedatives; Lorazepam; Psychiatric Department, Hospital; Psychotic Disorders; Risperidone; Sertraline | 2020 |
Three Cases of COVID-19-related First Onset Brief Reactive Psychosis.
Topics: Adult; Antipsychotic Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Delusions; Haloperidol; Humans; Involuntary Treatment; Lorazepam; Male; Olanzapine; Pandemics; Paranoid Behavior; Pneumonia, Viral; Psychotic Disorders; SARS-CoV-2; Social Isolation; Treatment Outcome | 2020 |
ABH Gel: Comforting Cure or Pricey Placebo?
Topics: Antipsychotic Agents; Diphenhydramine; Haloperidol; Hospices; Humans; Lorazepam; Palliative Care | 2021 |
Midazolam with haloperidol versus lorazepam with haloperidol for agitation: Effect on emergency department lengths of stay.
Topics: Antipsychotic Agents; Drug Therapy, Combination; Emergency Service, Hospital; Haloperidol; Humans; Lorazepam; Midazolam; Psychomotor Agitation | 2022 |
Prospective study of haloperidol plus lorazepam versus droperidol plus midazolam for the treatment of acute agitation in the emergency department.
Topics: Antipsychotic Agents; Droperidol; Emergency Service, Hospital; Haloperidol; Humans; Lorazepam; Midazolam; Prospective Studies; Psychomotor Agitation | 2022 |
Efficacy of Combination Haloperidol, Lorazepam, and Diphenhydramine vs. Combination Haloperidol and Lorazepam in the Treatment of Acute Agitation: A Multicenter Retrospective Cohort Study.
Topics: Adult; Antipsychotic Agents; Diphenhydramine; Haloperidol; Humans; Hypotension; Lorazepam; Muscarinic Antagonists; Oxygen; Psychomotor Agitation; Retrospective Studies | 2022 |
Visual compatibility and particle counter evaluations of syringes of intramuscular psychotropic coadministered solutions.
Topics: Diphenhydramine; Haloperidol; Humans; Lorazepam; Psychotropic Drugs; Syringes | 2023 |
Comparison of Droperidol and Midazolam Versus Haloperidol and Lorazepam for Acute Agitation Management in the Emergency Department.
Topics: Antipsychotic Agents; Droperidol; Emergency Service, Hospital; Haloperidol; Humans; Injections, Intramuscular; Lorazepam; Midazolam; Psychomotor Agitation; Retrospective Studies | 2023 |
Acute Treatment of Adolescent Cannabinoid Hyperemesis Syndrome With Haloperidol, Lorazepam, and/or Capsaicin: A Single Institution Case Series.
Topics: Adolescent; Adult; Cannabinoids; Capsaicin; Child; Haloperidol; Humans; Lorazepam; Nausea; Syndrome; Vomiting | 2023 |
Percutaneous absorption and Skin accumulation of Lorazepam-Diphenhydramine- Haloperidol Carbopol gel in Porcine Ear Skin.
Topics: Animals; Diphenhydramine; Haloperidol; Lorazepam; Skin Absorption; Swine | 2023 |